TP53 and acute lymphoblastic leukemia: In addition to these two cases from our cohort, we review nine published cases with <i>KMT2A</i> amplification in B-ALL, which showed frequent <i>TP53</i> alterations, emphasizing the clinical and genetic characteristics of this aggressive leukemia subtype.